Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Combivir for Patients With Primary Biliary Cirrhosis

This study has been completed.
Axcan Pharma
Information provided by:
University of Alberta Identifier:
First received: June 21, 2007
Last updated: October 31, 2007
Last verified: October 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2007
  Estimated Primary Completion Date: No date given